{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:42:57Z","timestamp":1770752577356,"version":"3.50.0"},"reference-count":95,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T00:00:00Z","timestamp":1641254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Combination antiretroviral therapy (cART) effectively blocks HIV replication but cannot completely eliminate HIV from the body mainly due to establishment of a viral reservoir. To date, clinical strategies designed to replace cART for life and alternatively to eliminate the HIV reservoir have failed. The reduced expression of viral antigens in the latently infected cells is one of the main reasons behind the failure of the strategies to purge the HIV reservoir. This situation has forced the scientific community to search alternative therapeutic strategies to control HIV infection. In this regard, recent findings have pointed out extracellular vesicles as therapeutic agents with enormous potential to control HIV infection. This review focuses on their role as pro-viral and anti-viral factors, as well as their potential therapeutic applications.<\/jats:p>","DOI":"10.3389\/fimmu.2021.811471","type":"journal-article","created":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T04:45:08Z","timestamp":1641271508000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Extracellular Vesicles as a New Promising Therapy in HIV Infection"],"prefix":"10.3389","volume":"12","author":[{"given":"Maria A.","family":"Navarrete-Mu\u00f1oz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Llorens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 M.","family":"Benito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norma","family":"Rall\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,4]]},"reference":[{"key":"B1","volume-title":"Global Aids Update","year":"2020"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(03)13802-0","article-title":"Decline in the AIDS and Death Rates in the EuroSIDA Study: An Observational Study","volume":"362","author":"Mocroft","year":"2003","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/387188a0","article-title":"Decay Characteristics of HIV-1-Infected Compartments During Combination Therapy","volume":"387","author":"Perelson","year":"1997","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1086\/597093","article-title":"Incomplete Peripheral CD4+ Cell Count Restoration in Hiv-Infected Patients Receiving Long-Term Antiretroviral Treatment","volume":"48","author":"Kelley","year":"2009","journal-title":"Clin Infect Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000545","article-title":"The Effect of HAART-Induced HIV Suppression on Circulating Markers of Inflammation and Immune Activation","volume":"29","author":"Wada","year":"2015","journal-title":"AIDS"},{"key":"B6","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/cei.12814","article-title":"Ageing and Inflammation in Patients With HIV Infection","volume":"187","author":"Nasi","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-016-0321-0","article-title":"Lipid Abnormalities and Inflammation in HIV Infection","volume":"13","author":"Funderburg","year":"2016","journal-title":"Curr HIV\/AIDS Rep"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e0147484","DOI":"10.1371\/journal.pone.0147484","article-title":"Pro-Inflammatory Markers in Relation to Cardiovascular Disease in HIV Infection. A Systematic Review","volume":"11","author":"Vos","year":"2016","journal-title":"PloS One"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e0149601","DOI":"10.1371\/journal.pone.0149601","article-title":"Higher Levels of Osteoprotegerin and Immune Activation\/Immunosenescence Markers Are Correlated With Concomitant Bone and Endovascular Damage in HIV-Suppressed Patients","volume":"11","author":"D\u2019Abramo","year":"2016","journal-title":"PloS One"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix167","article-title":"Antiretrovirals, Fractures, and Osteonecrosis in a Large International HIV Cohort","volume":"64","author":"Borges","year":"2017","journal-title":"Clin Infect Dis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328351f68f","article-title":"Association of Tenofovir Exposure With Kidney Disease Risk in HIV Infection","volume":"26","author":"Scherzer","year":"2012","journal-title":"AIDS"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s13365-015-0382-7","article-title":"Long-Term Efavirenz Use Is Associated With Worse Neurocognitive Functioning in HIV-Infected Patients","volume":"22","author":"Ma","year":"2016","journal-title":"J Neurovirol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":"Combination Antiretroviral Therapy and the Risk of Myocardial Infarction","volume":"349","author":"Friis-M\u00f8ller","year":"2003","journal-title":"N Engl J Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802905","article-title":"Long-Term Control of HIV by CCR5 Delta32\/Delta32 Stem-Cell Transplantation","volume":"360","author":"H\u00fctter","year":"2009","journal-title":"N Engl J Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1027-4","article-title":"HIV-1 Remission Following CCR5\u039432\/\u039432 Haematopoietic Stem-Cell Transplantation","volume":"568","author":"Gupta","year":"2019","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.688747","article-title":"Knowledge From London and Berlin: Finding Threads to a Functional HIV Cure","volume":"12","author":"Ding","year":"2021","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e1003211","DOI":"10.1371\/journal.ppat.1003211","article-title":"Post-Treatment HIV-1 Controllers With a Long-Term Virological Remission After the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study","volume":"9","author":"S\u00e1ez-Ciri\u00f3n","year":"2013","journal-title":"PloS Pathog"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1371\/journal.pmed.0010036","article-title":"Limited Durability of Viral Control Following Treated Acute HIV Infection","volume":"1","author":"Kaufmann","year":"2004","journal-title":"PloS Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/nature12744","article-title":"Therapeutic Efficacy of Potent Neutralizing HIV-1-Specific Monoclonal Antibodies in SHIV-Infected Rhesus Monkeys","volume":"503","author":"Barouch","year":"2014","journal-title":"Nature"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv046","article-title":"Safety and Immunogenicity of a Modified Vaccinia Ankara-Based HIV-1 Vaccine (MVA-B) in HIV-1-Infected Patients Alone or in Combination With a Drug to Reactivate Latent HIV-1","volume":"70","author":"Mothe","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9091026","article-title":"Current Status of HIV-1 Vaccines","volume":"9","author":"Hargrave","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-014-0102-z","article-title":"Human Semen Contains Exosomes With Potent Anti-HIV-1 Activity","volume":"11","author":"Madison","year":"2014","journal-title":"Retrovirology"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00247","article-title":"Human Intestinal Epithelial Cells Release Antiviral Factors That Inhibit HIV Infection of Macrophages","volume":"9","author":"Guo","year":"2018","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2016.07.013","article-title":"Exosomes Contribute to the Transmission of Anti-HIV Activity From TLR3-Activated Brain Microvascular Endothelial Cells to Macrophages","volume":"134","author":"Sun","year":"2016","journal-title":"Antiviral Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000514886","article-title":"Exosomes Transport Anti-Human Immunodeficiency Virus Factors From Human Cervical Epithelial Cells to Macrophages","volume":"3","author":"Xu","year":"2021","journal-title":"J Innate Immun"},{"key":"B26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.virol.2015.03.040","article-title":"Exosomes in Human Semen Restrict HIV-1 Transmission by Vaginal Cells and Block Intravaginal Replication of LP-BM5 Murine AIDS Virus Complex","volume":"482","author":"Madison","year":"2015","journal-title":"Virology"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00731-18","article-title":"Semen Exosomes Promote Transcriptional Silencing of HIV-1 by Disrupting NF-\u03bab\/Sp1\/Tat Circuitry","volume":"92","author":"Welch","year":"2018","journal-title":"J Virol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000002233","article-title":"Semen Extracellular Vesicles From HIV-1-Infected Individuals Inhibit HIV-1 Replication In Vitro, and Extracellular Vesicles Carry Antiretroviral Drugs In Vivo","volume":"83","author":"Welch","year":"2020","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001236","article-title":"Human Vaginal Fluid Contains Exosomes That Have an Inhibitory Effect on an Early Step of the HIV-1 Life Cycle","volume":"30","author":"Smith","year":"2016","journal-title":"AIDS"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000987","article-title":"Treatment Interruption in Chronically HIV-Infected Patients With an Ultralow HIV Reservoir","volume":"30","author":"Calin","year":"2016","journal-title":"AIDS"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/44755","article-title":"Re-Emergence of HIV After Stopping Therapy","volume":"401","author":"Chun","year":"1999","journal-title":"Nature"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1126\/science.278.5341.1295","article-title":"Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy","volume":"278","author":"Finzi","year":"1997","journal-title":"Science"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2016.01.006","article-title":"HIV-1 Reservoirs During Suppressive Therapy","volume":"24","author":"Barton","year":"2016","journal-title":"Trends Microbiol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/487439a","article-title":"HIV: Shock and Kill","volume":"487","author":"Deeks","year":"2012","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1172\/JCI92684","article-title":"Interval Dosing With the HDAC Inhibitor Vorinostat Effectively Reverses HIV Latency","volume":"127","author":"Archin","year":"2017","journal-title":"J Clin Invest"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e1004473","DOI":"10.1371\/journal.ppat.1004473","article-title":"Activation of HIV Transcription With Short-Course Vorinostat in HIV-Infected Patients on Suppressive Antiretroviral Therapy","volume":"10","author":"Elliott","year":"2014","journal-title":"PloS Pathog"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.09.020","article-title":"Replication-Competent Non-Induced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure","volume":"155","author":"Ho","year":"2013","journal-title":"Cell"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.03060","article-title":"Current Status of Latency Reversing Agents Facing the Heterogeneity of HIV-1 Cellular and Tissue Reservoirs","volume":"24","author":"Ait-Ammar","year":"2020","journal-title":"Front Microbiol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-816053-4.00007-9","article-title":"Emerging Therapeutic Roles of Exosomes in HIV-1 Infection","volume":"7","author":"Pang","year":"2020","journal-title":"Exosomes"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201211138","article-title":"Extracellular Vesicles: Exosomes, Microvesicles, and Friends","volume":"200","author":"Raposo","year":"2013","journal-title":"J Cell Biol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1042\/BST0370181","article-title":"The ESCRT Pathway and HIV-1 Budding","volume":"37","author":"Usami","year":"2009","journal-title":"Biochem Soc Trans"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1831413100","article-title":"The Trojan Exosome Hypothesis","volume":"100","author":"Gould","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/cmi.12046","article-title":"Sequences Within RNA Coding for HIV-1 Gag P17 Are Efficiently Targeted to Exosomes","volume":"15","author":"Columba Cabezas","year":"2013","journal-title":"Cell Microbiol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.438895","article-title":"Exosomes Derived From HIV-1-Infected Cells Contain Trans-Activation Response Element RNA","volume":"288","author":"Narayanan","year":"2013","journal-title":"J Biol Chem"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e106006","DOI":"10.1371\/journal.pone.0106006","article-title":"Novel HIV-1 miRNAs Stimulate TNFalpha Release in Human Macrophages via TLR8 Signaling Pathway","volume":"9","author":"Bernard","year":"2014","journal-title":"PloS One"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.662171","article-title":"Exosomes From HIV-1-Infected Cells Stimulate Production of Pro-Inflammatory Cytokines Through Trans-Activating Response (TAR) RNA","volume":"291","author":"Sampey","year":"2016","journal-title":"J Biol Chem"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e158","DOI":"10.1371\/journal.pbio.0050158","article-title":"Higher-Order Oligomerization Targets Plasma Membrane Proteins and HIV Gag to Exosomes","volume":"5","author":"Fang","year":"2007","journal-title":"PloS Biol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0854.2009.01006.x","article-title":"HIV Nef Is Secreted in Exosomes and Triggers Apoptosis in Bystander CD4+ T Cells","volume":"11","author":"Lenassi","year":"2010","journal-title":"Traffic"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e113691","DOI":"10.1371\/journal.pone.0113691","article-title":"Nef Neutralizes the Ability of Exosomes From CD4+ T Cells to Act as Decoys During HIV-1 Infection","volume":"9","author":"de Carvalho","year":"2014","journal-title":"PloS One"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1753","article-title":"HIV-1 Evades Virus-Specific IgG2 and IgA Responses by Targeting Systemic and Intestinal B Cells via Long-Range Intercellular Conduits","volume":"10","author":"Xu","year":"2009","journal-title":"Nat Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800372","article-title":"HIV-1 Nef Hijacks Lck and Rac1 Endosomal Traffic To Dually Modulate Signaling-Mediated and Actin Cytoskeleton-Mediated T Cell Functions","volume":"201","author":"Del R\u00edo-I\u00f1iguez","year":"2018","journal-title":"J Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e1007907","DOI":"10.1371\/journal.ppat.1007907","article-title":"Exosomes Containing HIV Protein Nef Reorganize Lipid Rafts Potentiating Inflammatory Response in Bystander Cells","volume":"15","author":"Mukhamedova","year":"2019","journal-title":"PloS Pathog"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200535615","article-title":"Direct Exosome Stimulation of Peripheral Human T Cells Detected by ELISPOT","volume":"36","author":"Admyre","year":"2006","journal-title":"Eur J Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1084\/jem.183.3.1161","article-title":"B Lymphocytes Secrete Antigen-Presenting Vesicles","volume":"183","author":"Raposo","year":"1996","journal-title":"J Exp Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.95676","article-title":"Exosomal Tat Protein Activates Latent HIV-1 in Primary, Resting CD4+ T Lymphocytes","volume":"3","author":"Tang","year":"2018","journal-title":"JCI Insight"},{"key":"B56","doi-asserted-by":"publisher","first-page":"15611","DOI":"10.1038\/s41598-017-15961-x","article-title":"Effects of Exosome on the Activation of CD4+ T Cells in Rhesus Macaques: A Potential Application for HIV Latency Reactivation","volume":"7","author":"Hong","year":"2017","journal-title":"Sci Rep"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-017-3391-4","article-title":"Trans-Dissemination of Exosomes From HIV-1-Infected Cells Fosters Both HIV-1 Trans-Infection in Resting CD4+ T Lymphocytes and Reactivation of the HIV-1 Reservoir","volume":"162","author":"Chiozzini","year":"2017","journal-title":"Arch Virol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M117.793521","article-title":"Exosomes From Uninfected Cells Activate Transcription of Latent HIV-1","volume":"292","author":"Barclay","year":"2017","journal-title":"J Biol Chem"},{"key":"B59","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12977-015-0216-y","article-title":"Latent HIV-1 Is Activated by Exosomes From Cells Infected With Either Replication-Competent or Defective HIV-1","volume":"12","author":"Arenaccio","year":"2015","journal-title":"Retrovirology"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01712-14","article-title":"Exosomes From Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Cells License Quiescent CD4+ T Lymphocytes to Replicate HIV-1 Through a Nef- and ADAM17-Dependent Mechanism","volume":"88","author":"Arenaccio","year":"2014","journal-title":"J Virol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02344-17","article-title":"Nef Secretion Into Extracellular Vesicles or Exosomes Is Conserved Across Human and Simian Immunodeficiency Viruses","volume":"9","author":"McNamara","year":"2018","journal-title":"mBio"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1102244","article-title":"Biochemical and Biologic Characterization of Exosomes and Microvesicles as Facilitators of HIV-1 Infection in Macrophages","volume":"189","author":"Kadiu","year":"2012","journal-title":"J Immunol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1038\/s41598-017-01739-8","article-title":"Extracellular Vesicles Carry HIV Env and Facilitate Hiv Infection of Human Lymphoid Tissue","volume":"7","author":"Arakelyan","year":"2017","journal-title":"Sci Rep"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e1000131","DOI":"10.1371\/journal.ppat.1000131","article-title":"HIV-1 Nef Targets MHC-I and CD4 for Degradation via a Final Common \u03b2-COP-Dependent Pathway in T Cells","volume":"4","author":"Schaefer","year":"2008","journal-title":"PloS Pathog"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e07-03-0218","article-title":"HIV-1 Nef-Induced Down-Regulation of MHC Class I Requires AP-1 and Clathrin But Not PACS-1 and is Impeded by AP-2","volume":"18","author":"Lubben","year":"2007","journal-title":"Mol Biol Cell"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00548-09","article-title":"Human Immunodeficiency Virus Type 1 Nef Protein Targets CD4 to the Multivesicular Body Pathway","volume":"83","author":"Da Silva","year":"2009","journal-title":"J Virol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-385987-7.00005-1","article-title":"HIV Immune Evasion Disruption of Antigen Presentation by the HIV Nef Protein","volume":"80","author":"Wonderlich","year":"2011","journal-title":"Adv Virus Res"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.3.1969","article-title":"Exosomes With Immune Modulatory Features Are Present in Human Breast Milk","volume":"179","author":"Admyre","year":"2007","journal-title":"J Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2016.03.004","article-title":"HIV-Nef and ADAM17-Containing Plasma Extracellular Vesicles Induce and Correlate With Immune Pathogenesis in Chronic HIV Infection","volume":"6","author":"Lee","year":"2016","journal-title":"EBioMedicine"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3791\/53495","article-title":"Isolation of Exosomes From the Plasma of HIV-1 Positive Individuals","author":"Konadu","year":"2016","journal-title":"J Vis Exp"},{"key":"B71","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/QAD.0000000000002794","article-title":"Circulating Extracellular Vesicles as New Inflammation Marker in HIV Infection","volume":"35","author":"Falasca","year":"2021","journal-title":"AIDS"},{"key":"B72","doi-asserted-by":"publisher","first-page":"e0201144","DOI":"10.1371\/journal.pone.0201144","article-title":"Cytokine Profiling of Exosomes Derived From the Plasma of HIV-Infected Alcohol Drinkers and Cigarette Smokers","volume":"13","author":"Kodidela","year":"2018","journal-title":"PloS One"},{"key":"B73","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.ebiom.2016.10.027","article-title":"HIV Nef- and Notch1-Dependent Endocytosis of ADAM17 Induces Vesicular TNF Secretion in Chronic HIV Infection","volume":"13","author":"Ostalecki","year":"2016","journal-title":"EBioMedicine"},{"key":"B74","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12865-020-00386-5","article-title":"Small RNA Sequencing of Extracellular Vesicles Identifies Circulating miRNAs Related to Inflammation and Oxidative Stress in HIV Patients","volume":"21","author":"Chettimada","year":"2020","journal-title":"BMC Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00757-18","article-title":"Induction of HIF-1\u03b1 by HIV-1 Infection in CD4+ T Cells Promotes Viral Replication and Drives Extracellular Vesicle-Mediated Inflammation","volume":"9","author":"Duette","year":"2018","journal-title":"mBio"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/77498","article-title":"Transfer of the Chemokine Receptor CCR5 Between Cells by Membrane-Derived Microparticles: A Mechanism for Cellular Human Immunodeficiency Virus 1 Infection","volume":"6","author":"Mack","year":"2000","journal-title":"Nat Med"},{"key":"B77","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/00002030-200301030-00006","article-title":"Platelet- and Megakaryocyte-Derived Microparticles Transfer CXCR4 Receptor to CXCR4-Null Cells and Make Them Susceptible to Infection by X4-HIV","volume":"17","author":"Rozmyslowicz","year":"2003","journal-title":"AIDS"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1126\/science.273.5283.1856","article-title":"Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study","volume":"273","author":"Dean","year":"1996","journal-title":"Science"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02629-08","article-title":"Noncytotoxic Suppression of Human Immunodeficiency Virus Type 1 Transcription by Exosomes Secreted From CD8+ T Cells","volume":"83","author":"Tumne","year":"2009","journal-title":"J Virol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01658-08","article-title":"Exosomes Packaging APOBEC3G Confer Human Immunodeficiency Virus Resistance to Recipient Cells","volume":"83","author":"Khatua","year":"2009","journal-title":"J Virol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/1873-3468.13653","article-title":"Semen Exosomes Inhibit HIV Infection and HIV-Induced Proinflammatory Cytokine Production Independent of the Activation State of Primary Lymphocytes","volume":"594","author":"Welch","year":"2020","journal-title":"FEBS Lett"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000159","article-title":"Exosomes From Breast Milk Inhibit HIV-1 Infection of Dendritic Cells and Subsequent Viral Transfer to CD4+ T Cells","volume":"28","author":"N\u00e4slund","year":"2014","journal-title":"AIDS"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics10040218","article-title":"Exosomes and Exosome-Inspired Vesicles for Targeted Drug Delivery","volume":"10","author":"Antimisiaris","year":"2018","journal-title":"Pharmaceutics"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3967\/bes2018.027","article-title":"Therapeutic Potential of Anti-HIV RNA-Loaded Exosomes","volume":"31","author":"Qiu","year":"2018","journal-title":"BioMed Environ Sci"},{"key":"B85","doi-asserted-by":"publisher","first-page":"e130","DOI":"10.1093\/nar\/gks463","article-title":"Plasma Exosomes Can Deliver Exogenous Short Interfering RNA to Monocytes and Lymphocytes","volume":"40","author":"Wahlgren","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.03.021","article-title":"Functional Delivery of Lipid-Conjugated siRNA by Extracellular Vesicles","volume":"25","author":"O'Loughlin","year":"2017","journal-title":"Mol Ther"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3390\/v12050486","article-title":"Repurposing Antiviral Protease Inhibitors Using Extracellular Vesicles for Potential Therapy of COVID-19","volume":"12","author":"Kumar","year":"2020","journal-title":"Viruses"},{"key":"B88","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s12015-020-10002-z","article-title":"Mesenchymal Stem Cell Derived Exosomes: A Nano Platform for Therapeutics and Drug Delivery in Combating COVID-19","volume":"17","author":"Pinky","year":"2021","journal-title":"Stem Cell Rev Rep"},{"key":"B89","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/febs.15558","article-title":"Exosomes as Mediators of Immune Regulation and Immunotherapy in Cancer","volume":"288","author":"Kugeratski","year":"2021","journal-title":"FEBS J"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.03.075","article-title":"Novel CD8+ T Cell-Based Vaccine Stimulates Gp120-Specific CTL Responses Leading to Therapeutic and Long-Term Immunity in Transgenic HLA-A2 Mice","volume":"30","author":"Nanjundappa","year":"2012","journal-title":"Vaccine"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.10.010","article-title":"A Strategy of Antigen Incorporation Into Exosomes: Comparing Cross-Presentation Levels of Antigens Delivered by Engineered Exosomes and by Lentiviral Virus-Like Particles","volume":"30","author":"Lattanzi","year":"2012","journal-title":"Vaccine"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3390\/v12060665","article-title":"Extracellular Vesicle Activation of Latent HIV-1 Is Driven by EV-Associated C-Src and Cellular SRC-1 via the PI3K\/AKT\/mTOR Pathway","volume":"12","author":"Barclay","year":"2020","journal-title":"Viruses"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7863412","article-title":"Detection of HIV-1 and Human Proteins in Urinary Extracellular Vesicles From HIV+ Patients","volume":"2018","author":"Anyanwu","year":"2018","journal-title":"Adv Virol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jmb.2009.08.023","article-title":"Structural Basis of HIV-1 Activation by NF-Kappab\u2014a Higher-Order Complex of P50:RelA Bound to the HIV-1 LTR","volume":"393","author":"Stroud","year":"2009","journal-title":"J Mol Biol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.15.5974","article-title":"Tumor Necrosis Factor Alpha Activates Human Immunodeficiency Virus Type 1 Through Induction of Nuclear Factor Binding to the NF-Kappa B Sites in the Long Terminal Repeat","volume":"86","author":"Duh","year":"1989","journal-title":"Proc Natl Acad Sci USA."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.811471\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T04:45:15Z","timestamp":1641271515000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.811471\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,4]]},"references-count":95,"alternative-id":["10.3389\/fimmu.2021.811471"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.811471","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,4]]},"article-number":"811471"}}